Evolv Technology Appoints Mario Ramos as Chief Financial Officer
02 November 2021 - 7:05AM
Business Wire
– Company Welcomes Experienced Fortune 5
Executive to Support Growth Plans –
Evolv Technology (NASDAQ: EVLV), the global leader in weapons
detection security screening, today announced the appointment of
Mario Ramos to the position of Chief Financial Officer effective
November 1, 2021. Mr. Ramos will assume global responsibility for
the Company's accounting, finance, risk compliance, information
technology and investor relations functions.
Mr. Ramos joins Evolv Technology from Edelman Financial Engines
where he served as Executive Vice President, Chief Financial
Officer and Chief Risk Officer. Edelman Financial Engines is the
nation’s top independent financial planning and investment
management firm serving over one million customers. Mr. Ramos will
succeed Mr. Peter Faubert, who is transitioning to a new role and
will serve as the Company’s Senior Vice President of Strategic
Finance.
"We are delighted to welcome Mario to the management team," said
Mr. Peter George, Chief Executive Officer of Evolv Technology.
"Mario brings over 20 years of executive experience building and
leading high-growth companies. I believe Mario's financial and
strategic leadership will be instrumental in supporting the
Company's next stage of growth."
"I'm excited to be joining Evolv Technology, the leader in
weapons detection security screening," said Mr. Ramos. "I look
forward to leveraging my finance and operations experience to help
Evolv execute its strategic plan and grow its leadership position
in one the fastest growing markets across the technology
industry.”
Prior to joining Edelman Financial Engines in 2019, Mr. Ramos
served as Senior Vice President and Chief Financial Officer of CVS
Caremark, the pharmacy benefits management subsidiary of CVS Health
(NYSE: CVS). Before becoming Caremark’s Chief Financial Officer,
Mr. Ramos was head of CVS’s M&A and Corporate Development group
where, among other things, he led CVS’s acquisition and integration
of Aetna. He has also served as Chief Operating Officer of CVS
International and spent over 17 years in investment banking
primarily at JP Morgan and Lehman Brothers. Mr. Ramos earned an MBA
from The Mason School of Business at The College of William &
Mary and a Bachelor’s Degree from The University of Richmond.
About Evolv Technology
Evolv Technology (NASDAQ: EVLV) is the global leader in weapons
detection security screening. Our mission is enabling a better
experience and better security for venues, creating a safer world
to work, learn, and play by transforming physical security to make
everywhere safer. This enhances the visitor experience and improves
weapons detection. We give sports fans, theme park visitors,
concertgoers, shoppers, employees, students, and others peace of
mind so that they can gather without fear of violence. Our security
system, delivered as a SaaS-based offering, has scanned more than
100 million people, second only to the Department of Homeland
Security’s Transportation Security Administration in the United
States, and our technology combines powerful, advanced sensors with
proven artificial intelligence (AI), security ecosystem
integrations, and comprehensive venue analytics to reliably detect
threats 10 times faster than traditional metal detectors.
Evolv Technology, Evolv Express®, Evolv Insights™, and Evolv
Cortex AI™ are registered trademarks or trademarks of Evolv
Technologies, Inc. in the United States and other jurisdictions.
For more information, visit https://evolvtechnology.com.
Forward-Looking Statements
Certain statements in this press release may constitute
“forward-looking” statements and information, within the meaning of
Section 27A of the Securities Act of 1933, Section 21E of the
Securities Exchange Act of 1934, and the safe harbor provisions of
the U.S. Private Securities Litigation Reform Act of 1995 that
relate to our current expectations and views of future events. All
statements other than statements of historical facts contained in
this press release are forward-looking statements. In some cases,
these forward-looking statements can be identified by words or
phrases such as “may,” “will,” “expect,” “should,” “could,”
“anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,”
“potential,” “continue,” “is/are likely to” or the negative of
these terms or other similar expressions. These forward-looking
statements are subject to risks, uncertainties and assumptions,
some of which are beyond our control. In addition, these
forward-looking statements reflect our current views with respect
to future events or our Company’s performance and are not a
guarantee of future performance. Actual outcomes may differ
materially from the information contained in the forward-looking
statements as a result of a number of factors, including, without
limitation expectations regarding Evolv’s strategies and future
financial performance and other risk factors set forth under the
caption “Risk Factors” in our proxy statement/prospectus, filed
with the Securities and Exchange Commission (the “SEC”) on June 28,
2021, as updated by the risk factors disclosed in the section
titled “Risk Factors” in our Form 8-K, filed with the SEC on July
22, 2021, and in our other documents filed with or furnished to the
SEC.
These statements reflect management’s current expectations
regarding future events and operating performance and speak only as
of the date of this press release. You should not put undue
reliance on any forward-looking statements. Although we believe
that the expectations reflected in the forward-looking statements
are reasonable, we cannot guarantee that future results, levels of
activity, performance and events and circumstances reflected in the
forward-looking statements will be achieved or will occur. Except
as required by law, we undertake no obligation to update or revise
publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, after the date on which
the statements are made or to reflect the occurrence of
unanticipated events.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211101005808/en/
Investor Relations: Brian Norris Vice President of
Investor Relations bnorris@evolvtechnology.com
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Jul 2023 to Jul 2024